Ascentage Pharma logo

Ascentage Pharma

134 employees · est. 2009 · China

VS
InGeneron logo

InGeneron

Unlocking Regenerative Cell Therapy

18 employees · est. 2006 · Houston, United States

InGeneron is the older company (2009 vs 2006); Ascentage Pharma is the larger of the two.

Side-by-Side Comparison

Ascentage Pharma InGeneron
Founded
2009 2006 older
Headquarters
China Houston, United States
Employees
134 larger 18
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Post Ipo Equity Series Unknown
Total Funding
$740.50M $52.75M
Funding Rounds
4 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Clinical-stage, Therapies, Cancer, CHB, Senesce Diseases, Apoptosis Inhibitors, Bcl-2 Inhibitors, Bcl-xL Inhibitors, MDM2-p53 Inhibitors, Tyrosine Kinase Inhibitors, Drug Development, Clinical Trials, Small-molecule Therapies, Hepatitis B Regenerative Cell Therapy, Clinical-stage Biotechnology, Orthopedic Conditions, Minimally Invasive Treatments, Cell Therapy Product Platform, Stem And Regenerative Cell Research, Autologous Adult Stem Cells, FDA-approved Therapies, Healthcare Innovation, Point-of-care Treatments
Website
ascentagepharma.com ingeneron.com
Ascentage Pharma logo

About Ascentage Pharma

Ascentage Pharma is a global, clinical-stage biotechnology company established in 2009 and headquartered in China. The company focuses on developing innovative therapies for cancers, CHB, and senesce diseases. On October 28, 2019, Ascentage Pharma was listed on the Main Board of the Stock Exchange o...

InGeneron logo

About InGeneron

InGeneron is a clinical-stage biotechnology company that aims to revolutionize healthcare with its novel, safe, and evidence-based cell therapies. The company's mission revolves around unlocking the healing potential of each patient’s own regenerative cells processed at the point of care to enable s...

We will tell you when either one moves

BounceWatch watches Ascentage Pharma and InGeneron for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ascentage Pharma and InGeneron — by email.

Frequently Asked Questions

Ascentage Pharma. InGeneron — Unlocking Regenerative Cell Therapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ascentage Pharma has raised $740.50M while InGeneron has raised $52.75M.
Ascentage Pharma and InGeneron operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ascentage Pharma with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ascentage Pharma on 12 Sep 2024, and InGeneron on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy